Local senolysis in aged mice only partially replicates the benefits of systemic senolysis
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Clearance of senescent cells (SnCs) can prevent several age-related pathologies, including bone loss. However, the local versus systemic roles of SnCs in mediating tissue dysfunction remain unclear. Thus, we developed a mouse model (p16-LOX-ATTAC) that allowed for inducible SnC elimination (senolysis) in a cell-specific manner and compared the effects of local versus systemic senolysis during aging using bone as a prototype tissue. Specific removal of Sn osteocytes prevented age-related bone loss at the spine, but not the femur, by improving bone formation without affecting osteoclasts or marrow adipocytes. By contrast, systemic senolysis prevented bone loss at the spine and femur and not only improved bone formation, but also reduced osteoclast and marrow adipocyte numbers. Transplantation of SnCs into the peritoneal cavity of young mice caused bone loss and also induced senescence in distant host osteocytes. Collectively, our findings provide proof-of-concept evidence that local senolysis has health benefits in the context of aging, but, importantly, that local senolysis only partially replicates the benefits of systemic senolysis. Furthermore, we establish that SnCs, through their senescence-associated secretory phenotype (SASP), lead to senescence in distant cells. Therefore, our study indicates that optimizing senolytic drugs may require systemic instead of local SnC targeting to extend healthy aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although as noted earlier, P1NP could also justifiably have been chosen as our primary outcome based on our animal data13,14.”
From Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the observation from our preclinical studies that senescent osteocytes remained reduced in mice following 4 months of monthly D + Q administration, with similar findings noted in our genetic clearance models13,14.”
From Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sost mRNA levels are reduced in osteocyte-enriched bone samples in old mice following senescent cell clearance13,14”
From Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Therefore, the aim of this phase 2 RCT was to examine whether our findings in aged mice demonstrating both anabolic and antiresorptive effects of intermittent senolytic therapy on bone metabolism13,14, were applicable to humans.”
From Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial (2024) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“Traditionally, these models contain luminescent or fluorescent reporter systems yielding increased signal dependent upon the expression level of p21 or p168,83,104–107.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [83]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationGeroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“These findings inspired the discovery of a class of drugs known as senolytics that selectively kill SnCs as a therapeutic approach to extend healthy aging (11).”
Self-citationBonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287 · cited 1×
“…mice crossed with the heterogeneity of most tissues, bone is abundantly populated by osteocytes (comprising >95% of all skeletal cells) (13); (b) spatial and temporal control of precise gene manipulations in osteocytes using the Cre-loxP system is facilitated by a well-characterized…”
Senolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287 · cited 3×
“…has previously shown that transplanted cells (both Sn and non-Sn control) remain detectable in vivo for only up to 40 days after transplantation (42), we next asked whether at 60 days after SnC transplantation, beyond the point these cells are no longer detectable, the transplanted SnCs induced…”
Self-citationHulsen, T., de Vlieg, J., & Alkema, W. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-488 · Cited by 1,674
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · cited 1×
“With aging, SnCs have increased expression of p16 Ink4a in several mammalian tissues (20), whereas p21 Cip1 seems to be induced by cells under acute duress leading to senescence in other circumstances (21), including tissue repair (22, 23).”
Facing up to the global challenges of ageing
Partridge, L., Deelen, J., & Slagboom, P. E. (2018) · Nature · doi:10.1038/s41586-018-0457-8 · Cited by 1,475
Cited by
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“In both ageing and the disease states listed above, skeletal cellular senescence can also be observed through histological staining of SA-β-gal activity 203 , SADS 93,200,204,205 and TAF 200,203,204 , typically in bone-embedded osteocytes 206 .”
Self-citationGuidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
Self-citationSenescence as a therapeutic target in cancer and age-related diseases
McHugh, D., Durán, I., & Gil, J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01074-4 · Cited by 197
“The above models enable the elimination of all cell types, but there are models such as p16-LOX-ATTAC mice that allow for Cre-dependent elimination of a specific type of SnC to achieve local senolysis 191 .”
Hou, J., Chen, K.-X., He, C., Li, X., Huang, M., Jiang, Y., Jiao, Y., Xiao, Q.-N., He, W., Liu, L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00694-0 · Cited by 165
“Elimination of senescent cells 8,43,44 has emerged as a plausible therapeutic approach for preventing, delaying or alleviating multiple diseases and age-related dysfunction 3,45–49 .”
Farr, J. N., Atkinson, E. J., Achenbach, S. J., Volkman, T. L., Tweed, A. J., Vos, S. J., Ruan, M., Sfeir, J., Drake, M. T., Saul, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03096-2 · Cited by 127
“…our previous studies in aged mice had demonstrated a reduction in bone resorption and increase in bone formation following seno-lytic treatment 13,14 , the choice of whether to assign CTx or P1NP as the primary endpoint was entirely arbitrary, particularly in the absence of any previous human…”
InfluentialSelf-citationInflammatory Processes Affecting Bone Health and Repair
de Oliveira, H. T., Arnold, K. M., Oviedo, M., Westendorf, J. J., & Weaver, S. R. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00824-4 · Cited by 150
“Senescent cells and their associated SASP factors are present in the bone microenvironment of old mice [174], and reducing the systemic senescent cell burden prevents age-related bone loss [175, 176].”
Telomeres, cellular senescence, and aging: past and future
Eppard, M., Passos, J. F., & Victorelli, S. G. (2023) · Biogerontology · doi:10.1007/s10522-023-10085-4 · Cited by 71
“…of p16 Ink4a -positive cells have been shown to reduce TAF in the aorta (Roos et al. 2016), liver (Ogrodnik et al. 2017), heart (Anderson et al. 2019), brain (Ogrodnik et al. 2019), bone (Chandra et al. 2020), and adipose tissue (Farr et al. 2023; Ogrodnik et al. 2019; Xu et al. 2018) of mice.”
Self-citationSaul, D., Doolittle, M. L., Rowsey, J. L., Froemming, M. N., Kosinsky, R. L., Vos, S. J., Ruan, M. M., LeBrasseur, N. K., Chandra, A., Pignolo, R. J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179834 · Cited by 49
Self-citationCardiomyocyte senescence and the potential therapeutic role of senolytics in the heart
Zhai, P., & Sadoshima, J. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.06 · Cited by 51
“This mouse model was developed in order to achieve p16 INK4a -mediated expression of ATTAC in a tissue-specific manner [63] .”
MethodIL-23R is a senescence-linked circulating and tissue biomarker of aging
Carver, C. M., Rodriguez, S. L., Atkinson, E. J., Dosch, A. J., Asmussen, N. C., Gomez, P. T., Leitschuh, E. A., Espíndola‐Netto, J. M., Jeganathan, K. B., Whaley, M. G., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00752-7 · Cited by 43
“…(SA-β-gal) whole-body transgenic targeting of p16-postitive cells demonstrated greater benefits in aged bone composition following systemic clearance, which supports the notion that the adverse influence of senescent cells and the SASP results from both local and distant signaling 28 .”
Self-citationCellular senescence offers distinct immunological vulnerabilities in cancer
Zhou, L., Ma, B., & Ruscetti, M. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.010 · Cited by 45
Franco, A. C., Martini, H., Victorelli, S. G., Lagnado, A. B., Wyles, S. P., Rowsey, J. L., Pirius, N., Woo, S., Costa, D. G., Chaib, S., et al. (2024) · Aging Cell · doi:10.1111/acel.14340 · Cited by 39
Self-citationTargeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 40
Self-citationSenescent cells as a target for anti-aging interventions: From senolytics to immune therapies
Fu, T., & Zhou, Z. (2025) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2025-0005 · Cited by 44
“…modulation and elimination were generated using Cre-LoxP recombination, such as the p16-LOX-ATTAC and p21-Cre mouse that monitor and manipulate p16 Ink4a+ and p21 high cells in mice, [15,16] facilitating deeper insight into the link between senescent cell burden and organ-specific pathologies.”
Kaur, J., Adhikari, M., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., Stambough, J. B., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0857 · Cited by 37
Self-citationThe ageing immune system as a driver of systemic ageing
Jang, I. H., Niedernhofer, L. J., Robbins, P. D., & Camell, C. D. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01269-3 · Cited by 45
“Mouse models in which p16 Ink4a+ and p21 Cip1+ senescent cells can be eliminated in a cell-type-specific and tissue-type-specific manner 178 are needed to determine if reducing the elevated inflammation caused by the increased senescent cell burden is sufficient or if senotherapeutics directly…”
Self-citationCellular senescence and frailty: a comprehensive insight into the causal links
Marcozzi, S., Bigossi, G., Giuliani, M. E., Giacconi, R., Piacenza, F., Cardelli, M., Brunetti, D., Segala, A., Valerio, A., Nisoli, E., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00960-w · Cited by 28
“Indeed, senescence cells, at least partly through the SASP, can induce secondary senescence even in distant non-senescent cells [63–65].”
BackgroundResultCharacterization of Human Senescent Cell Biomarkers for Clinical Trials
Farr, J. N., Monroe, D. G., Atkinson, E. J., Froemming, M. N., Ruan, M. M., LeBrasseur, N. K., & Khosla, S. (2025) · Aging Cell · doi:10.1111/acel.14489 · Cited by 28
“This is of interest, as in our previous work (Farr et al. 2023), we found that p16 Ink4a expression starts to increase in osteocyte-enriched bone samples from mice at ~18 months of age.”
Self-citationEndothelial senescent-cell-specific clearance alleviates metabolic dysfunction in obese mice
Suda, M., Chaib, S., Prata, L. G. P. L., Zhu, Y. Z., Tripathi, U., Paul, K. H., Palmer, A. K., Pirtskhalava, T., Kulshreshtha, V., Inman, C. L., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.009 · Cited by 28
Self-citationDeconstructing cellular senescence in bone and beyond
Hofbauer, L. C., Lademann, F., & Rauner, M. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169069 · Cited by 17
Wu, H., Zhang, Q., Zhu, J., Wu, L., Xiao, Y., & Yang, X. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.002 · Cited by 35
“While contributing to aging-related pathologies, they also facilitate wound healing and tissue repair through temporally regulated secretory activities [186,187].”
Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart
Maggiorani, D., Santin, Y., Formoso, K., Drapé, E., Martini, H., Brun, S., Cousin, G., Lairez, O., Lezoualc’h, F., Parini, A., et al. (2024) · Aging Cell · doi:10.1111/acel.14204 · Cited by 15
Meslier, Q. A., Oehrlein, R., & Shefelbine, S. J. (2025) · Aging Cell · doi:10.1111/acel.70087 · Cited by 16
Jiang, B., Zhang, H., Xu, Q., Jiang, Z., He, R., Fu, Q., & Sun, Y. (2025) · Aging Cell · doi:10.1111/acel.70138 · Cited by 14
“…of senescent cells in both preclinical models and clinical trials, supporting the adverse influences of senescent cells, particularly those mediated by their critical hallmark, the SASP, which can generate remarkable impact on overall health conditions in a chronic manner (Farr et al. 2023).”
Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related Diseases
Liu, J., Yu, H., & Xu, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071727 · Cited by 15
“Experiments in the INK-ATTAC mouse model provide direct evidence: the genetic depletion of senescent osteocytes and osteoblasts alleviates age-related bone loss, further confirming the promoting role of cellular senescence and the SASP in OP development [162].”
Miyagawa, K., Tenshin, H., Mulcrone, P. L., Delgado‐Calle, J., Subler, M. A., Windle, J. J., Chirgwin, J. M., Roodman, G. D., & Kurihara, N. (2023) · JCI Insight · doi:10.1172/jci.insight.159838 · Cited by 13
Identified senescence endotypes in aged cartilage are reflected in the blood metabolome
Boone, I., Tuerlings, M., de Almeida, R. C., Lehmann, J., Ramos, Y. F., Nelissen, R. G. H. H., Slagboom, P. E., de Keizer, P. L. J., & Meulenbelt, I. (2023) · GeroScience · doi:10.1007/s11357-023-01001-2 · Cited by 14
“Moreover, Farr and colleagues [28] recently demonstrated that systemic administration of senolytics, hence body-wide clearance, was more effective to reduce bone dysfunction as compared to local administration in mice.”
BackgroundSkeletal Senescence with Aging and Type 2 Diabetes
Farr, J. N. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1727 · Cited by 14
“The SASP produced by non-immune cells can also spread senescence to previously healthy cells [44,45], including to osteocytes in bone [46].”
BackgroundSelf-citationSenescence of skeletal stem cells and their contribution to age-related bone loss
Wölfel, E. M., Guerra, P. F., Nørgård, M. Ø., Jeromdesella, S., Kjær, P. K., Elkjaer, A. S., Kassem, M. S., & Figeac, F. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111976 · Cited by 17
Stiffening symphony of aging: Biophysical changes in senescent osteocytes
Tilton, M., Weivoda, M. M., Potes, M. D. A., Gingery, A., Liu, A. Y., Tchkonia, T., Lu, L., & Kirkland, J. L. (2024) · Aging Cell · doi:10.1111/acel.14421 · Cited by 12
“Overall, these observations align with previous studies 19,20,22,33,34 that have shown senescent osteocytes exhibit increased p16 Ink4a expression with age, contributing to reduced bone remodeling capacity.”
InfluentialSelf-citationTilton, M., Liao, J., Kim, C., Shaygani, H., Potes, M. D. A., Cordova, D. J., Kirkland, J. L., & Miller, K. M. (2025) · Small · doi:10.1002/smll.202408517 · Cited by 14
Self-citationQuarato, E. R., Salama, N., & Calvi, L. M. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00874-2 · Cited by 11
“These approaches have been remarkably successful in delaying aspects of aging including bone loss [162–165], inflammation, and progression of disease (like osteoarthritis) [166, 167].”
Regulation of the Osteocyte Secretome with Aging and Disease
Kitase, Y., & Prideaux, M. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01089-w · Cited by 14
“However, it was recently shown that the beneficial effects of global senolysis on aged bone health are not soley due to removal of senescent osteocytes [89].”
BackgroundPignolo, R. J., & Chandra, A. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112025 · Cited by 11
Self-citationKhan, T., Hussain, A. I., Casilli, T. P., Frayser, L. A., Cho, M., Williams, G., McFall, D. J., & Forcelli, P. A. (2024) · Aging Cell · doi:10.1111/acel.14239 · Cited by 9
“Genetic tools to clear senescent cells in specific cells/tissues only recently became readily available and demonstrated that local senolysis in aged tissue partially replicates the benefits of systemic senolysis (Farr et al., 2023).”
BackgroundYeo, D., Fisher, E. L. Z., Khosla, S., Farr, J. N., & Westendorf, J. J. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae085 · Cited by 7
Self-citationMarrow Adipocyte Senescence in the Pathogenesis of Bone Loss
Froemming, M. N., Khosla, S., & Farr, J. N. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00875-1 · Cited by 7
Self-citationA Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain
Orr, M. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231462 · Cited by 6
Senescent Schwann cells as therapeutic targets in nerve regeneration and peripheral neuropathies
Rebolledo, D. L., Khan, M. A., Melov, S., Höke, A., & Court, F. A. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.01.003 · Cited by 6
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 9
Khosla, S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180558 · Cited by 4
“%) can cause local as well as systemic tissue damage or dysfunction (7).”
Self-citationCommunication breakdown: senescent cells in interorgan communication of aging
Ghosh, R. B., Dipali, S. S., Desdín-Micó, G., & Yousefzadeh, M. J. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.02.002 · Cited by 5
Osteoimmune senescence in aging-related bone diseases
Li, H., Yang, Y., & Zhu, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892334 · Cited by 5
Cellular senescence and nanoparticle-based therapies: Current developments and perspectives
Henschke, A., Mielcarek, A., Grześkowiak, B. F., Perrigue, P. M., Jaskot, K., Coy, E. L., & Moya, S. E. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2023-0211 · Cited by 6
“Khosla ’ s team highlighted that the therapy may require a more systemic approach [123,124].”
BackgroundSpreading Senescent Cells’ Burden and Emerging Therapeutic Targets for Frailty
Marcozzi, S., Bigossi, G., Giuliani, M. E., Lai, G., Giacconi, R., Piacenza, F., & Malavolta, M. (2023) · Cells · doi:10.3390/cells12182287 · Cited by 4
Miwa, S., Fielder, E., Ishaq, A., Low, E., Laws, J., Calista, A., Castle, J., & von Zglinicki, T. (2024) · doi:10.59368/agingbio.20240022 · Cited by 5
“In fact, recent results indicate that local, cell-type-specific senolysis can be less effective than systemic senolysis, even in the targeted organ 85 .”
Delgado‐Calle, J., Adhikari, M., Kaur, J., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4047486/v1 · Cited by 3
“Notably, global genetic clearance of senescent cells results in greater benefits than osteocyte-specific clearance in aging, suggesting the involvement of additional senescent cell populations in bone preservation (40).”
BackgroundSelf-citationBun, M., Ukon, Y., Ikuta, M., Kitahara, T., Furuichi, T., Hirai, H., Tateiwa, D., Kanie, Y., Furuya, M., Fujimori, T., et al. (2025) · Aging Cell · doi:10.1111/acel.70331 · Cited by 2
“Second, D + Q administration improves both cortical and trabecular bone structures in aged mice; however, approximately 4 months of treatment are typically required to achieve this effect (Farr et al. 2023; Farr et al. 2017).”
A Senolytic Strategy for Metabolic Health: Why the Endothelium Matters
Liang, H., Wang, Y., Zhang, Y., & Tang, X. (2026) · iNew Medicine · doi:10.1002/inm3.70026 · Cited by 5
Παπανικολάου, Κ., Yadav, A., Mankowski, R. T., Alexander, M. S., Gamboa, J. L., Thalacker‐Mercer, A. E., Dungan, C. M., & Englund, D. A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00876.2025 · Cited by 2
Jiang, F., Dong, B., Wang, Y., & Xiong, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104322 · Cited by 3
“Recent transcriptomic analyses in murine models have revealed that pro-inflammatory cytokines and immune dysfunction can induce osteocyte senescence [87].”
Senotypes define the diverse landscape of senescent cells
Schafer, M. J., Basisty, N., Hertzel, A. V., Rindone, A. N., Elisseeff, J. H., Suryadevara, V., Aliferis, C., Robbins, P. D., Niedernhofer, L. J., Miller, K. N., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01148-5 · Cited by 8
Self-citationFielder, E., Ishaq, A., Low, E., Laws, J., Calista, A., Castle, J., von Zglinicki, T., & Miwa, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.23.554476 · Cited by 2
Zhou, J., Chen, K., & Li, Z. (2025) · Bioelectromagnetics · doi:10.1002/bem.70035 · Cited by 1
“Osteocytes, the most abundant bone cells, orchestrate bone re-modeling by modulating osteoblast and osteoclast activity, making them a potential therapeutic target for OP (Farr et al. 2023; M. Yan et al. 2023).”
Yamashita, A., Tenshin, H., Matsuki, S., Nishino, G., Ser-Od, S., Saito, F. M., Hiasa, M., & Tanaka, E. I. (2026) · JBMR Plus · doi:10.1093/jbmrpl/ziag014 · Cited by 2
Fielder, E., Ishaq, A., Low, E., Laws, J., Calista, A., Castle, J., von Zglinicki, T., & Miwa, S. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4631509 · Cited by 1
Reproducible in vivo applications of the p16-3MR model in senescence researchPreprint
Wang, B., Picallos-Rabina, P., Nehme, J., & Demaria, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.28.701695 · Cited by 2
Senescent Subtypes Transition ModelPreprint
Singh, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.10.544466
“Local senolysis can only partially replicates the benefits seen at the systemic senolysis [34].”
Backgroundwang, Y.-X., Wang, L., Chen, H., Yang, B., zhang, G.-F., Wang, J., Fei, W., Cai, J., Ruan, B., Liu, Z., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4143931/v1
Dupont, J., Dejaeger, M., Laurent, M. R., & Gielen, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00010-8
Stiffening Symphony of Aging: How Senescent Osteocytes Lose Their Elastic RhythmPreprint
Tilton, M., Weivoda, M. M., Potes, M. D. A., Gingery, A., Liu, A. Y., Tchkonia, T., Lu, L., & Kirkland, J. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.28.615588
Self-citationAging and rejuvenation of engineered cardiovascular tissues: from research to clinical application
Liu, C. X., Guo, J., Zhang, Y., Hu, M., Hao, T., Crețoiu, D., Li, G., & Xiao, J. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.11 · Cited by 1
Azad, T. D., Li, M., Chiu, P.-Y., Jones, K. E., Lord, E. L., Molina, C. A., Walker, C. T., Osorio, J. A., Pizones, J., Theologis, A. A., et al. (2025) · Spine Deformity · doi:10.1007/s43390-025-01124-w · Cited by 1
“Critically, it appears that in the context of bone health, both local senescent cells and those at distant sites contribute to the aged-bone phenotype, as targeting only local senescent cells does not fully replicate the benefits of systemic senolysis [20].”
Urrego, C. A., Sexton, B., & Kohn, D. H. (2025) · Bone · doi:10.1016/j.bone.2025.117665
Application of senescence reporter mouse models in panvascular diseases
Li, H., Zhang, Y., Tian, Z., & Zhang, S. (2025) · Vessel Plus · doi:10.20517/2574-1209.2025.99 · Cited by 1
Brain irradiation drives remote liver changes via senescence-independent mechanisms
Jiang, Y., Voshart, D. C., Gustinelli, A., Scholma, A. C., Hageman, E., Nazario, L. R., Brouwer, U., Demaria, M., Coppes, R. P., & Barazzuol, L. (2026) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2026.111373
Monitoring senescent cell dynamics in wound healing using a p16-tdtomato mouse model
Wang, Q., Shvedova, M., Abdelkader, M., & Roh, D. S. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.12.029
Liu, Z., Peng, Y., Hou, J., Zhang, G., & 王晋东 (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1727398 · Cited by 2
“…cells can effectively reduce osteoclast numbers in aged mice, specific local clearance of senescent osteocytes (local senolysis) only improves bone formation and microstructure but does not replicate the effect of reduced osteoclasts (OCs) observed with systemic clearance (Farr et al., 2023).”
Kitase, Y., Prideaux, M., Bellido, T., Pajevic, P. D., & Bonewald, L. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00043-8
Bone marrow skeletal stem cell dysfunction: Adipocytes during skeletal aging and senescence
Komel, A., Achudhan, D., & Chandra, A. (2026) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2026.100608
Sun, Y., Zou, H., Cui, A., Dong, H., Abulizi, P., Zhao, P., Wang, J., Leung, W. K., & Wang, Q. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116647
Distinct fibroblast and perivascular senotypes define spatial niches that regulate fibrosisPreprint
Rindone, A. N., Nagaraj, S., Cho, A., Browne, M., Krishnan, K., Adkins, R. S., Lesperance, D., Orvis, J., Daswani, P. S., Mejías, J. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730636 · Cited by 1
Liu, X., Zheng, H., Wang, A., Liu, J., Chen, Z., Chen, Y., Yang, G., Chen, D., Zhang, Y., & Yuan, G. (2026) · Bone Research · doi:10.1038/s41413-026-00570-0
Osteocyte State Transitions Modulate Bone Remodeling During Early Skeletal AgingPreprint
Denda, R., Liu, A., Hayashi, M., Wang, C., Akiyama, H., Takayanagi, H., Saito, M., & Nakashima, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.07.743422
The senescence–immune axis as a target for combining immunotherapy and senotherapy
Saez‐Calazans, F., Grün, L. K., Stein, L. E., Barbé‐Tuana, F. M., & Filippi‐Chiela, E. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103309
Insights Into the Interplay Between the Senescent Cells and Immune Cells
Jaros, M., Schmidt, M., Neubert, L., Kamp, J. C., von Vietinghoff, S., Bräsen, J. H., Schmitt, R., & Melk, A. (2026) · Aging Cell · doi:10.1111/acel.70698
“Local and cell type-specific clearance models would provide approaches to distinguish renal cell-autonomous effects from systemic effects (Farr et al. 2023; Suda et al. 2025).”
Guo, T.-T., Hong-xin, Z., & Jiang, Q.-D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1949165
Brooks, H. W., Cusick, N. C., Wu, S., & Farr, J. N. (2026) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2026.102203
Self-citationCellular senescence: six decades of discovery and reinvention
Klaver, M., Steeneken, L. S., Veeningen, N., Altulea, A., & Demaria, M. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00922-w
Tissue coordination in ageing and disease
Cleal, K. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103422
Zhuang, J., & Yu, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1979955
Metadata
- Authors
- Farr, J. N., Saul, D., Doolittle, M. L., Kaur, J., Rowsey, J. L., Vos, S. J., Froemming, M. N., Lagnado, A. B., Zhu, Y., Weivoda, M., Ikeno, Y., Pignolo, R. J., Niedernhofer, L. J., Robbins, P. D., Jurk, D., Passos, J. F., LeBrasseur, N. K., Tchkonia, T., Kirkland, J. L., Monroe, D. G., & Khosla, S.
- Affiliations
- Mayo Clinic (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Minnesota (US)
- Corresponding author
- Farr, Joshua N.
- Khosla, Sundeep
- ORCID
- Farr, Joshua N.
- Saul, Dominik
- Doolittle, Madison L.
- Kaur, Japneet
- Rowsey, Jennifer L.
- Froemming, Mitchell N.
- Lagnado, Anthony B.
- Zhu, Yi
- Weivoda, Megan
- Ikeno, Yuji
- Pignolo, Robert J.
- Niedernhofer, Laura J.
- Robbins, Paul D.
- Jurk, Diana
- Passos, João F.
- LeBrasseur, Nathan K.
- Kirkland, James L.
- Monroe, David G.
- Khosla, Sundeep
- Venue
- Journal of Clinical Investigation
- Published
- 2023-04-17
- Volume
- 133
- Issue
- 8
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10104901
- OpenAlex
- W4321445705
- Cited by
- 81
- References
- 54
- Citations by year
- 2026: 26 · 2025: 15 · 2024: 28 · 2023: 12
- FWCI
- 14.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Aging (AG062413,AG076515,AG068048,AG013925,AG063543,AG056278,AG063707)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK128552)
- National Cancer Institute (UG3CA26810)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- senolysis, senescent cells, aging, age-related bone loss, osteocytes, senescence-associated secretory phenotype, osteoclasts, bone formation, senolytics, healthy aging
- MeSH terms
- Aging, Animals, Bone and Bones, Osteoclasts, Osteocytes, Cellular Senescence, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.